STAQ Pharma operates in the pharmaceutical outsourcing market, specializing in sterile injectable medical compounding. The company serves healthcare facilities by providing compounded medications, particularly IV push medications, that meet stringent safety and quality standards. STAQ Pharma's business model revolves around its state-of-the-art 503B outsourcing facility, which complies with cGMP (current Good Manufacturing Practice) regulations. This facility ensures the production of high-quality, sterile injectable medications in large batches, which are then sold to healthcare providers. The company generates revenue by manufacturing and selling these compounded medications, ensuring they are available when needed by healthcare facilities. STAQ Pharma emphasizes transparency by providing detailed quality management reports and certificates of analysis for each batch. The company also employs advanced inventory systems to forecast needs and maintain critical product availability.

Keywords: sterile injectable compounding, 503B outsourcing, cGMP compliance, IV push medications, healthcare facilities, transparency, quality management, inventory systems, pediatric patients, pharmaceutical outsourcing.